NorthStrive Biosciences Partners with Charles River Laboratories to Advance Its EL-22 and EL-32 Engineered Probiotic Programs
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| (NASDAQ: ELAB) | Delayed: 2.66 -0.12 (4.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.78 | 52 Week High | $ | |||
| Open | $2.70 | 52 Week Low | $ | |||
| Day High | $2.77 | P/E | N/A | |||
| Day Low | $2.62 | EPS | $ | |||
| Volume | 5,017 | |||||
